PEPTONIC Medical AB Logo

PEPTONIC Medical AB

Develops clinically proven self-care products for women's intimate health.

PMED | SPGR

Overview

Corporate Details

ISIN(s):
SE0005962206 (+2 more)
LEI:
213800QRUS3DHXGTFA20
Country:
Sweden
Address:
Färögatan 33, 24 tr, 164 51 Kista
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PEPTONIC Medical AB is a biomedical company specializing in women's intimate health. The company focuses on the research, development, and commercialization of clinically proven self-care products. Its strategy is to offer a comprehensive portfolio that enables consumers to diagnose, treat, and prevent intimate health conditions. The flagship brand, VagiVital, provides solutions for issues such as vaginal atrophy, positioning the company's offerings between prescription medications and general consumer goods. PEPTONIC Medical expands its global reach through direct sales of its brands and through partnerships via licensing and white-label models, supported by a portfolio of intellectual property.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all PEPTONIC Medical AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PEPTONIC Medical AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PEPTONIC Medical AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Orexo Logo
Develops pharmaceuticals & digital health for opioid use disorder in the US market.
Sweden ORX
Orion Oyj Logo
Develops and manufactures human/vet pharma, APIs, and generics for global markets.
Finland ORNAV
Orum Therapeutics, Inc. Logo
Developing degrader-antibody conjugates for cell-selective protein degradation to treat cancer.
South Korea 475830
Otsuka Holdings Co., Ltd. Logo
Global healthcare group creating pharmaceuticals and nutraceuticals for worldwide well-being.
Japan 4578
Ovoca Bio Plc Logo
Biopharma developing a novel therapy for premenopausal women with low sexual desire (HSDD).
Ireland OVXA
Oxford Biomedica PLC Logo
A CDMO for cell & gene therapy, providing end-to-end viral vector development & manufacturing.
United Kingdom OXB
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC Logo
A former biopharma firm that developed non-addictive, cannabinoid-based pain therapies.
United Kingdom OCTHF
PAION AG Logo
Developed drugs for hospital-based sedation, anesthesia, and critical care.
Germany PA8
Pangen Biotech Inc. Logo
Develops biosimilars and provides CHO-based CDMO services for the global biopharma industry.
South Korea 222110
Pentixapharm Holding AG Logo
Develops radiopharmaceuticals for diagnosing and treating oncology and adrenal disorders.
Germany PTP

Talk to a Data Expert

Have a question? We'll get back to you promptly.